JP7323462B2 - セルフリーdnaによる移植患者のモニタリング - Google Patents
セルフリーdnaによる移植患者のモニタリング Download PDFInfo
- Publication number
- JP7323462B2 JP7323462B2 JP2019571025A JP2019571025A JP7323462B2 JP 7323462 B2 JP7323462 B2 JP 7323462B2 JP 2019571025 A JP2019571025 A JP 2019571025A JP 2019571025 A JP2019571025 A JP 2019571025A JP 7323462 B2 JP7323462 B2 JP 7323462B2
- Authority
- JP
- Japan
- Prior art keywords
- dna
- donor
- subject
- samples
- total
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762522570P | 2017-06-20 | 2017-06-20 | |
| US62/522,570 | 2017-06-20 | ||
| US201762576631P | 2017-10-24 | 2017-10-24 | |
| US62/576,631 | 2017-10-24 | ||
| US201862653213P | 2018-04-05 | 2018-04-05 | |
| US201862653517P | 2018-04-05 | 2018-04-05 | |
| US62/653,517 | 2018-04-05 | ||
| US62/653,213 | 2018-04-05 | ||
| US201862655030P | 2018-04-09 | 2018-04-09 | |
| US62/655,030 | 2018-04-09 | ||
| PCT/US2018/038609 WO2018237081A1 (en) | 2017-06-20 | 2018-06-20 | PATIENT MONITOR TRANSPLANT WITH ACELLULAR DNA |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020529194A JP2020529194A (ja) | 2020-10-08 |
| JP2020529194A5 JP2020529194A5 (cg-RX-API-DMAC7.html) | 2021-07-29 |
| JP7323462B2 true JP7323462B2 (ja) | 2023-08-08 |
Family
ID=64737312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019571025A Active JP7323462B2 (ja) | 2017-06-20 | 2018-06-20 | セルフリーdnaによる移植患者のモニタリング |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20210139983A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3642356A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7323462B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN110945144A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018288838A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3067635A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL271459A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018237081A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11111543B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
| US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
| US11111544B2 (en) | 2005-07-29 | 2021-09-07 | Natera, Inc. | System and method for cleaning noisy genetic data and determining chromosome copy number |
| US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11326208B2 (en) | 2010-05-18 | 2022-05-10 | Natera, Inc. | Methods for nested PCR amplification of cell-free DNA |
| US11332785B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11339429B2 (en) | 2010-05-18 | 2022-05-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| EP2854058A3 (en) | 2010-05-18 | 2015-10-28 | Natera, Inc. | Methods for non-invasive pre-natal ploidy calling |
| US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| US12221653B2 (en) | 2010-05-18 | 2025-02-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US12655483B2 (en) | 2010-05-18 | 2026-06-16 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
| US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US11332793B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| US12152275B2 (en) | 2010-05-18 | 2024-11-26 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
| AU2011348100B2 (en) | 2010-12-22 | 2016-08-25 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
| JP6153874B2 (ja) | 2011-02-09 | 2017-06-28 | ナテラ, インコーポレイテッド | 非侵襲的出生前倍数性呼び出しのための方法 |
| US20140100126A1 (en) | 2012-08-17 | 2014-04-10 | Natera, Inc. | Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data |
| PL3117012T5 (pl) | 2014-03-14 | 2026-03-16 | Caredx, Inc. | Sposoby monitorowania terapii immunosupresyjnych u biorcy przeszczepu |
| RU2717641C2 (ru) | 2014-04-21 | 2020-03-24 | Натера, Инк. | Обнаружение мутаций и плоидности в хромосомных сегментах |
| US20180173845A1 (en) | 2014-06-05 | 2018-06-21 | Natera, Inc. | Systems and Methods for Detection of Aneuploidy |
| EP4428863A3 (en) | 2015-05-11 | 2024-12-11 | Natera, Inc. | Methods and compositions for determining ploidy |
| JP7280044B2 (ja) | 2016-04-15 | 2023-05-23 | ナテラ, インコーポレイテッド | 肺癌の検出方法 |
| WO2018067517A1 (en) | 2016-10-04 | 2018-04-12 | Natera, Inc. | Methods for characterizing copy number variation using proximity-litigation sequencing |
| GB201618485D0 (en) | 2016-11-02 | 2016-12-14 | Ucl Business Plc | Method of detecting tumour recurrence |
| US10011870B2 (en) | 2016-12-07 | 2018-07-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
| CN110945136A (zh) | 2017-06-20 | 2020-03-31 | 威斯康星州立大学医学院 | 使用总无细胞dna评估移植并发症风险 |
| WO2019118926A1 (en) | 2017-12-14 | 2019-06-20 | Tai Diagnostics, Inc. | Assessing graft suitability for transplantation |
| EP3737773B1 (en) | 2018-01-12 | 2023-04-12 | Natera, Inc. | Novel primers and uses thereof |
| DK3781714T3 (da) | 2018-04-14 | 2026-03-30 | Natera Inc | Fremgangsmåder til cancerpåvisning og -overvågning ved personlig påvisning af cirkulerende tumor-dna |
| US12234509B2 (en) | 2018-07-03 | 2025-02-25 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
| EP3847280A1 (en) | 2018-09-07 | 2021-07-14 | Sequenom, Inc. | Methods, and systems to detect transplant rejection |
| US20220093208A1 (en) * | 2019-02-19 | 2022-03-24 | Sequenom, Inc. | Compositions, methods, and systems to detect hematopoietic stem cell transplantation status |
| CA3135853A1 (en) * | 2019-04-03 | 2020-10-08 | The Medical College Of Wisconsin, Inc. | Transplant patient monitoring with cell-free dna |
| US11931674B2 (en) | 2019-04-04 | 2024-03-19 | Natera, Inc. | Materials and methods for processing blood samples |
| US12305235B2 (en) | 2019-06-06 | 2025-05-20 | Natera, Inc. | Methods for detecting immune cell DNA and monitoring immune system |
| WO2022015676A1 (en) * | 2020-07-13 | 2022-01-20 | The Medical College Of Wisconsin, Inc. | Methods for making treatment management decisions in transplant subjects and assessing transplant risks with threshold values |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011118603A1 (ja) | 2010-03-24 | 2011-09-29 | 凸版印刷株式会社 | 競合プライマーによる標的塩基配列の検出方法 |
| US20150086477A1 (en) | 2012-04-19 | 2015-03-26 | Medical College Of Wisconsin, Inc. | Highly sensitive surveillance using detection of cell free dna |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2496720T3 (da) * | 2009-11-06 | 2020-09-28 | Univ Leland Stanford Junior | Ikke-invasiv diagnose af transplantatafstødning i organ-transplanterede patienter |
| US20130123120A1 (en) * | 2010-05-18 | 2013-05-16 | Natera, Inc. | Highly Multiplex PCR Methods and Compositions |
| HK1217733A1 (zh) * | 2013-03-15 | 2017-01-20 | Immucor Gti Diagnostics, Inc. | 使用尿游离dna评估肾状态的方法和组合物 |
| PL3004388T5 (pl) * | 2013-05-29 | 2023-10-09 | Chronix Biomedical | Wykrywanie i oznaczanie ilościowe pozakomórkowego dna dawcy w układzie krążenia biorców przeszczepów organów |
| WO2015058194A1 (en) * | 2013-10-18 | 2015-04-23 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Allele specific pcr assay for detection of nucleotide variants |
| PL3117012T5 (pl) * | 2014-03-14 | 2026-03-16 | Caredx, Inc. | Sposoby monitorowania terapii immunosupresyjnych u biorcy przeszczepu |
| AU2016255573A1 (en) * | 2015-04-30 | 2017-12-21 | The Medical College Of Wisconsin, Inc. | Multiplexed optimized mismatch amplification (MOMA)-real time PCR for assessing cell-free DNA |
-
2018
- 2018-06-20 US US16/623,725 patent/US20210139983A1/en active Pending
- 2018-06-20 WO PCT/US2018/038609 patent/WO2018237081A1/en not_active Ceased
- 2018-06-20 EP EP18821381.3A patent/EP3642356A4/en active Pending
- 2018-06-20 CN CN201880049158.4A patent/CN110945144A/zh active Pending
- 2018-06-20 AU AU2018288838A patent/AU2018288838A1/en not_active Abandoned
- 2018-06-20 CA CA3067635A patent/CA3067635A1/en active Pending
- 2018-06-20 JP JP2019571025A patent/JP7323462B2/ja active Active
-
2019
- 2019-12-16 IL IL271459A patent/IL271459A/en unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011118603A1 (ja) | 2010-03-24 | 2011-09-29 | 凸版印刷株式会社 | 競合プライマーによる標的塩基配列の検出方法 |
| US20150086477A1 (en) | 2012-04-19 | 2015-03-26 | Medical College Of Wisconsin, Inc. | Highly sensitive surveillance using detection of cell free dna |
Non-Patent Citations (4)
| Title |
|---|
| BMC genomics, 2007, Vol.8, 275 (pp.1-9) |
| Clinical Chemistry,2009年,vol.55, no.11,p.1958-1966 |
| Mutat. Res., 1999, Vol.430, pp.1-12 |
| PLOS Medicine,2017年,vol.14, no.4,e1002286,p.1-19 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3642356A1 (en) | 2020-04-29 |
| CA3067635A1 (en) | 2018-12-27 |
| AU2018288838A1 (en) | 2020-01-16 |
| IL271459A (en) | 2020-01-30 |
| WO2018237081A1 (en) | 2018-12-27 |
| US20210139983A1 (en) | 2021-05-13 |
| JP2020529194A (ja) | 2020-10-08 |
| CN110945144A (zh) | 2020-03-31 |
| EP3642356A4 (en) | 2021-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220267849A1 (en) | Transplant patient monitoring with cell-free dna | |
| US20240026437A1 (en) | Assessing transplant complication risk with total cell-free dna | |
| US20220356522A1 (en) | Assessing conditions in transplant subjects using donor-specific cell-free dna | |
| US20210139983A1 (en) | Transplant patient monitoring with cell-free dna | |
| US20210139988A1 (en) | Assessing conditions in transplant subjects using donor-specific cell-free dna | |
| US20230167499A1 (en) | Methods for assessing risk using total cell-free dna | |
| EP3449019B1 (en) | Multiplexed optimized mismatch amplification (moma)-target number | |
| CN110177874A (zh) | 用于使用错配扩增和统计方法来评估风险的方法 | |
| CN107849604A (zh) | 用于评估无细胞dna的多重优化错配扩增(moma)实时pcr | |
| HK40029115B (en) | Assessing transplant complication risk with total cell-free dna | |
| HK40029115A (en) | Assessing transplant complication risk with total cell-free dna | |
| HK40005635B (en) | Multiplexed optimized mismatch amplification (moma)-target number | |
| HK40005635A (en) | Multiplexed optimized mismatch amplification (moma)-target number |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210621 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210621 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20220315 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220322 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20220622 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20220822 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220826 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20221130 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230331 |
|
| C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20230331 |
|
| C11 | Written invitation by the commissioner to file amendments |
Free format text: JAPANESE INTERMEDIATE CODE: C11 Effective date: 20230410 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230510 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20230529 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230627 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230727 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7323462 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |